ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

2-Methylindole → Methyl 1,2,3,4-tetrahydro-3-methyl-6-[(2-methyl-1H-indol-3-yl)methyl]-1-(isobutyl)-2,4-dioxothieno[2,3-d]pyrimidine-5-carboxylate

HRID 131557
印刷

反応式

HRID 131557 の反応式
ClC1N=C(C)N([CH2:8][C:9]2[S:24][C:12]3[N:13]([CH2:20][CH:21]([CH3:23])[CH3:22])[C:14](=[O:19])[N:15]([CH3:18])[C:16](=[O:17])[C:11]=3[C:10]=2C(N2C[C@H](O)CO2)=O)C=1Cl.BrN1C(=O)CC[C:36]1=O.[C:42](=[O:45])(O)[O-:43].[Na+].[CH3:47][C:48]1[NH:49][C:50]2[C:55]([CH:56]=1)=[CH:54][CH:53]=[CH:52][CH:51]=2>C(Cl)(Cl)Cl>[CH3:18][N:15]1[C:16](=[O:17])[C:11]2[C:10]([C:42]([O:43][CH3:36])=[O:45])=[C:9]([CH2:8][C:56]3[C:55]4[C:50](=[CH:51][CH:52]=[CH:53][CH:54]=4)[NH:49][C:48]=3[CH3:47])[S:24][C:12]=2[N:13]([CH2:20][CH:21]([CH3:22])[CH3:23])[C:14]1=[O:19]
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 4

HCID 72242-MethylindoleHCID 67184N-bromobutanimideHCID 516892Sodium BicarbonateHCID 101425596-[(4,5-Dichloro-2-methyl-1H-imidazol-1-yl)methyl]-5-[4-(S)-hydroxy-2-isoxazolidinylcarbonyl]-3-methyl-1-(isobutyl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione

生成物 1

HCID 68805728Methyl 1,2,3,4-tetrahydro-3-methyl-6-[(2-methyl-1H-indol-3-yl)methyl]-1-(isobutyl)-2,4-dioxothieno[2,3-d]pyrimidine-5-carboxylate

試薬・触媒・溶媒 1

HCID 6212Chloroform溶媒

実験手順

A solution of the product of example 3, part a), (7 g) and N-bromosuccinimide (4.42 g) in chloroform (140 ml) was refluxed under illumination from a tungsten lamp for 2 h. The solution was cooled to room temperature, saturated aqueous sodium bicarbonate solution (140 ml) and 2-methylindole (5.92 g) were added and the mixture stirred rapidly for 48 h. The phases were separated and the aqueous phase extracted with dichloromethane (100 ml). The combined organic extracts were dried over anhydrous magnesium sulfate, filtered and evaporated under reduced pressure. The residue was purified by column chromatography over silica, eluting with ethyl acetate/i-hexane (1:3) to give the sub-title compound as a pale brown solid (6.68 g). MS(ESI) 440 [M+H]+. δ 1HCDCl3 0.87 (6H, d), 2.11-2.21 (1H, m), 2.42 (3H, s), 3.38 (3H, s), 3.61 (2H, d), 3.99 (3H, s), 4.22 (2H, s), 7.08 (1H, t), 7.15 (1H, t), 7.31 (1H, d), 7.46 (1H, d), 7.91 (1H, s, br).

後処理

  1. customThe phases were separated
  2. extractionthe aqueous phase extracted with dichloromethane (100 ml)
  3. dry with materialThe combined organic extracts were dried over anhydrous magnesium sulfate
  4. filtrationfiltered
  5. customevaporated under reduced pressure
  6. customThe residue was purified by column chromatography over silica
  7. washeluting with ethyl acetate/i-hexane (1:3)

出典と根拠

ORDレコード
ord-a96c79dccaf74c48ae08fb7770008f4c
出典データセット
uspto-grants-2008_06
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07384950B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート